The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer

Authors
Publication date
1 August 2014
Publisher
'Publishing House ABV Press'
Doi

    Abstract

    The determination of mutant p53 and the basic parameters studied by DNA-flow cytofluorometry in combination with other clinical and morphological predictors may be used as additional prognostic criteria individually in each patient with breast cancer

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Directory of Open Access Journals

      redirect
      oaioai:doaj.org/article:b04176c53...
      Last time updated on 09/08/2016